Trial Profile
Follow-up study of L059 (levetiracetam) in epileptic patients with partial onset seizures by open label method.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Jun 2019
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors UCB Pharma Inc
- 15 Jan 2008 Status changed from in progress to completed.
- 03 Dec 2005 New trial record.